The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention
- PMID: 24410812
- PMCID: PMC3922789
- DOI: 10.1186/1878-5085-5-2
The efficacy of probiotics for monosodium glutamate-induced obesity: dietology concerns and opportunities for prevention
Abstract
Introduction: Obesity becomes endemic today. Monosodium glutamate was proved as obesogenic food additive. Probiotics are discussed to impact on obesity development.
Aims and objectives: The aim was to study the effects of probiotics on the development of monosodium glutamate (MSG)-induced obesity in rats.
Material and methods: We included 45 Wistar male rats and divided into three groups (n = 15). Newborn rats of group 1 (control) received subcutaneously 8 μl/g saline. Group 2 received 3 to 4 mg/g MSG subcutaneously on the second, fourth, sixth, eighth and tenth day of life. Within 4 months after birth, rats were on a standard diet. Group 3 received an aqueous solution of probiotics mixture (2:1:1 Lactobacillus casei IMVB-7280, Bifidobacterium animalis VKL, B. animalis VKB) at the dose of 5 × 109 CFU/kg (50 mg/kg) intragastrically. Administration of probiotics was started at the age of 4 weeks just after weaning and continued for 3 months during 2-week courses. Group 2 received intragastrically 2.5 ml/kg water. Organometric and biochemical parameters in all groups of rats were analyzed over 4 months. The concentration of adiponectin was determined in serum, and leptin - in adipose tissue.
Results: Administration of MSG led to the development of obesity in rats; body weight had increased by 7.9% vs controls (p < 0.05); body length had increased by 5.4% (p < 0.05). Body mass index and Lee index and visceral fat mass had increased (p < 0.001). Under the neonatal injection of MSG, the concentration of total cholesterol, triglycerides, VLDL cholesterol and LDL cholesterol significantly increased (p < 0.001), in comparison with controls. Adipose-derived hormones changed in MSG obesity rats: adiponectin decreased by 58.8% (p < 0.01), and leptin concentration in adipose tissue had increased by 74.7% (p < 0.01). The probiotic therapy of rats from group 3 prevented obesity development. Parameters of rats treated with probiotic mixture did not differ from that in the control.
Conclusions: The introduction of MSG to newborn rats caused the obesity in adulthood. Periodic administration of probiotic mixture to rat injected with MSG neonatally resulted in recovery of lipid metabolism and prevention of the obesity development.
Figures

Similar articles
-
Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.BMC Gastroenterol. 2016 Mar 15;16:34. doi: 10.1186/s12876-016-0451-2. BMC Gastroenterol. 2016. PMID: 26976285 Free PMC article.
-
[The effect of probiotic therapy on development of experimental obesity in rats caused by monosodium glutamate].Fiziol Zh (1994). 2014;60(2):63-9. Fiziol Zh (1994). 2014. PMID: 25007523 Ukrainian.
-
Short-term periodic consumption of multiprobiotic from childhood improves insulin sensitivity, prevents development of non-alcoholic fatty liver disease and adiposity in adult rats with glutamate-induced obesity.BMC Complement Altern Med. 2014 Jul 16;14:247. doi: 10.1186/1472-6882-14-247. BMC Complement Altern Med. 2014. PMID: 25030027 Free PMC article.
-
Probiotic strains of lactobacilli and bifidobacteria alter pro- and anti-inflammatory cytokines production in rats with monosodium glutamate-induced obesity.Fiziol Zh (1994). 2017;63(1):17-25. doi: 10.15407/fz63.01.017. Fiziol Zh (1994). 2017. PMID: 29975824
-
Probiotics for experimental obesity prevention: focus on strain dependence and viability of composition.Endokrynol Pol. 2017;68(6):659-667. doi: 10.5603/EP.a2017.0055. Epub 2017 Oct 12. Endokrynol Pol. 2017. PMID: 29022648
Cited by
-
Probiotics and Disease: A Comprehensive Summary-Part 3, Cardiometabolic Disease and Fatigue Syndromes.Integr Med (Encinitas). 2017 Feb;16(1):30-41. Integr Med (Encinitas). 2017. PMID: 28223906 Free PMC article. Review.
-
Impaired dopamine D1 receptor-mediated vasorelaxation of mesenteric arteries in obese Zucker rats.Cardiovasc Diabetol. 2014 Feb 22;13:50. doi: 10.1186/1475-2840-13-50. Cardiovasc Diabetol. 2014. PMID: 24559270 Free PMC article.
-
Effect of probiotics on obesity-related markers per enterotype: a double-blind, placebo-controlled, randomized clinical trial.EPMA J. 2020 Feb 7;11(1):31-51. doi: 10.1007/s13167-020-00198-y. eCollection 2020 Mar. EPMA J. 2020. PMID: 32140184 Free PMC article.
-
Comparative study of probiotic effects of Lactobacillus and Bifidobacteria strains on cholesterol levels, liver morphology and the gut microbiota in obese mice.EPMA J. 2017 Oct 10;8(4):357-376. doi: 10.1007/s13167-017-0117-3. eCollection 2017 Dec. EPMA J. 2017. PMID: 29209439 Free PMC article.
-
High regenerative capacity of the liver and irreversible injury of male reproductive system in carbon tetrachloride-induced liver fibrosis rat model.EPMA J. 2017 Oct 11;9(1):59-75. doi: 10.1007/s13167-017-0115-5. eCollection 2018 Mar. EPMA J. 2017. PMID: 29515688 Free PMC article.
References
-
- WHO. Obesity and overweight: Fact sheet N. 311. [ http://www.who.int/mediacentre/factsheets/fs311/en/]
-
- World Bank. An avoidable tragedy: combating Ukraine's health crisis - lessons from Europe. [ http://documents.worldbank.org/curated/en/2009/01/11550454/avoidable-tra...]
-
- Golubnitschaja O. In: Predictive Diagnostics and Personalized Treatment: Dream or Reality. Golubnitschaja O, editor. New York: Nova Science Publishers Inc; 2009. Diabetes mellitus; pp. 147–150.
LinkOut - more resources
Full Text Sources
Other Literature Sources